Public Reporting

The Shared Savings Program requires ACOs to create and maintain a dedicated webpage to publicly report required organizational and programmatic information, such as organizational contact information and performance results. CMS provides instructions to ACOs ahead of each public reporting cycle.”

ACO Name and Location

Crystal Run Healthcare ACO, LLC
155 Crystal Run Road
Middletown, New York 10941

ACO Primary Contact

Primary Contact Name Scott Hines, MD
Primary Contact Phone Number 845-703-6381
Primary Contact Email Address shines@crystalrunhealthcare.com

 

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Crystal Run Healthcare LLP No

 

ACO governing body:

Member Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Teitelbaum Hal Chief Executive Officer 14.2% ACO Participant Representative Crystal Run Healthcare LLP
Koury Michelle Chief Operating Officer 14.2% ACO Participant Representative Crystal Run Healthcare LLP
Spencer Gregory Chief Medical Officer 14.2% ACO Participant Representative Crystal Run Healthcare LLP
Nasser Jonathan Chief Clinical Transformation Officer 14.2% ACO Participant Representative Crystal Run Healthcare LLP
Hines Scott Chief Quality Officer 14.2% ACO Participant Representative Crystal Run Healthcare LLP
Sansted Douglas Chief Legal Officer 14.2% ACO Participant Representative Crystal Run Healthcare LLP
Walter Kenneth Board Member 14.2% ACO Participant Representative Crystal Run Healthcare LLP

 

Key ACO clinical and administrative leadership:

Hal Teitelbaum ACO Executive
Gregory Spencer Medical Director
Katie Owens Compliance Officer
Scott Hines Quality Assurance/Improvement Officer

  

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Value Based Care Committee Scott Hines & Jonathan Nasser (as above)
Practice Redesign Committee Jonathan Nasser (as above)
Best Practice Council Scott Hines (as above)
IT Committee Francis Cheung (Chief Information Officer)

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • N/A

 

Shared Savings Distribution

  • N/A

 

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 80.51
ACO-2 CAHPS: How Well Your Providers Communicate N/A 93.01
ACO-3 CAHPS: Patients’ Rating of Provider N/A 92.25
ACO-4 CAHPS: Access to Specialists N/A 83.49
ACO-5 CAHPS: Health Promotion and Education N/A 60.32
ACO-6 CAHPS: Shared Decision Making N/A 75.40
ACO-7 CAHPS: Health Status/Functional Status N/A 72.30
ACO-34 CAHPS: Stewardship of Patient Resources N/A 26.97
ACO-8 Risk Standardized, All Condition Readmission N/A 14.70
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented N/A 76.79
ACO-42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.